Kwong Lung Enterprise Co Ltd (8916) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Kwong Lung Enterprise Co Ltd stock TWD 47.58, price TWD 40.05, upside +18.8%, quality 65 out of 100. Rating: undervalued. Calculated from audited financials with 24 of our 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 8, 2026.
How to read this chart
60‑month range 27.75 TWD – 51.98 TWD · fair‑value band 32.32 TWD – 62.95 TWD · the 40.05 TWD price screens below the 47.58 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 8, 2026.
Follow Kwong Lung Enterprise Co in your weekly email
Every Wednesday you see whether Kwong Lung Enterprise Co is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Kwong Lung Enterprise Co., Ltd. engages in the manufacture and sale of apparel in Taiwan, China, Vietnam, and Japan. It operates through Apparel Department, Down Material Department, and Home Textile Department segments.
Show moreShow less
The company offers gore-tex garments; seam sealed; down jacket; padded outwear; sleeping bags; tents; and outdoor clothes and tactical pants for men and women. It also provides home textiles and bedding products to outdoor equipment; and down and feather products.
The company was incorporated in 1966 and is headquartered in Taipei, Taiwan.
Stock analysis
Kwong Lung Enterprise Co Ltd (8916) currently trades at 40.05 TWD, while our model-based Fair Value estimate is 47.58 TWD, implying the stock looks roughly 16% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 53.04 TWD per share, and 15 of the 24 models we run sit above the 40.05 TWD price.
Bear case: the Earnings-Based group reads lowest at 21.33 TWD, and 9 of the 24 models stay below the price. Data coverage for this calculation is high.
Scenario range: 32.32 TWD (bear) to 62.95 TWD (bull), the price of 40.05 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Consumer Cyclical sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Kwong Lung Enterprise Co Ltd reported revenue of 8.5B TWD in FY2025 versus 8.1B TWD in FY2021, a compound +1.4%/yr. Reported net income was 377M TWD in FY2025, compounding −7.5%/yr from FY2021.
Key figures
Market cap 6.0B TWD (≈ $183M) Micro · P/E ratio 14.0 · P/S ratio 0.74 · EPS (TTM) 2.86 TWD · Dividend yield 6.2% · Net margin 5.3% · Return on equity 8.6% · Return on assets (EBIT) 6.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 37 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 3% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Consumer Cyclical peers we cover trades at −8% fair-value upside, at 19%, 8916 screens cheaper than that median.
Fair Value models
Bear32.32 TWDFair Value 47.58 TWDBull62.95 TWD
Price 40.05 TWD · Upside +18.8%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.3087 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
+8.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−6.1%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.1%
Start year 2020 (pandemic)
Revenue growth 9 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−0.1%
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+12.1%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.9%
Dividend (yield on the price)6.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−6.1% vs −4.2%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.5% → 6%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Revenue per share shrinking 5.8%/yr over ~7Y (margins intact) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Price in line with expectations
The price assumes about as much growth as the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−0.4%
The company could shrink this much every year for the next five years and today's price would still be justified.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about −2.0% a year for the price.
Compare Kwong Lung Enterprise Co Ltd with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Textile Manufacturing · 336 stocks
Beats the industry median on 9/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score65 · Top 25%
Fair Value upside+18.8% · Above median
Profitability
Return on equity (12 months)8.6% · Above median
Return on assets3.9% · Above median
Net margin (12 months)5.3% · Above median
Operating margin (12 months)5.5% · Below median
Growth and dividend
Revenue growth (quarter YoY)−6.4% · Bottom 25%
Dividend yield (12 months)6.2% · Top 25%
Balance sheet
Debt / equity0.14× · Above median
Valuation Multiplesvs Textile Manufacturing median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Kwong Lung Enterprise Co Ltd Fair Value". https://www.fairvalue-calculator.com/stock/8916
Frequently asked questions
Is Kwong Lung Enterprise Co Ltd (8916) overvalued or undervalued?
As of Nov 8, 2026, our model estimates a fair value of 47.58 TWD versus a price of 40.05 TWD, about +19% upside (undervalued).
What is the fair value of 8916?
Our model-based fair value for Kwong Lung Enterprise Co Ltd is 47.58 TWD (as of Nov 8, 2026), built from audited fundamentals. The current price: 40.05 TWD.
What is the quality score of 8916?
Kwong Lung Enterprise Co Ltd has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kwong Lung Enterprise Co Ltd (8916)?
Our model-based price target is the fair value of 47.58 TWD (as of Nov 8, 2026) from 24 valuation models. Cautious scenario 32.32 TWD, optimistic scenario 62.95 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Kwong Lung Enterprise Co Ltd stock forecast for 2026?
Our models put fair value at 47.58 TWD, about +19% upside versus a price of 40.05 TWD (undervalued). Cautious scenario 32.32 TWD, optimistic scenario 62.95 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Kwong Lung Enterprise Co Ltd (8916)?
Kwong Lung Enterprise Co Ltd reported trailing-twelve-month revenue of about 8.2B TWD (latest available figure, as of Nov 8, 2026).
Does Kwong Lung Enterprise Co Ltd pay a dividend?
Kwong Lung Enterprise Co Ltd currently shows a dividend yield of 6.24% relative to its recent price (as of Nov 8, 2026).
How much is the dividend of Kwong Lung Enterprise Co Ltd (8916) and when is the ex-dividend date?
Kwong Lung Enterprise Co Ltd pays a dividend of 2.50 TWD per share a year, a dividend yield of 6.2%. The last ex-dividend date was Aug 12, 2026. A dividend has been paid every year since at least 2008. The payout ratio is 87.4% of earnings. Free cash flow covers the dividend 2.50 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Kwong Lung Enterprise Co Ltd (8916)?
For today's price to be fair in a discounted-cash-flow model, Kwong Lung Enterprise Co Ltd would have to grow free cash flow by -0.4 % per year for five years (discount rate 13.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.1 % per year. As of Nov 8, 2026.
What discount rate (WACC) does the fair value of 8916 use?
Our models discount Kwong Lung Enterprise Co Ltd at 13.3 %: a base by market capitalisation (micro), country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kwong Lung Enterprise Co Ltd that is -0.4 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (13.3 %) and the same formula as our fair value.
How much growth has Kwong Lung Enterprise Co Ltd (8916) delivered so far?
Over the past 5 years revenue at Kwong Lung Enterprise Co Ltd grew +0.1 % a year. The price currently implies free-cash-flow growth of -0.4 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kwong Lung Enterprise Co Ltd (8916) growing?
The median revenue growth in the sector is +4.8 % a year. That is the yardstick for the growth priced into Kwong Lung Enterprise Co Ltd (-0.4 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kwong Lung Enterprise Co Ltd (8916)?
The free-cash-flow yield on the price is 15.46 %: that much free cash flow Kwong Lung Enterprise Co Ltd produces per unit of market value. When it exceeds the discount rate of our models (13.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kwong Lung Enterprise Co Ltd (8916)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kwong Lung Enterprise Co Ltd it is 47.58 TWD per share (as of Nov 8, 2026), against a price of 40.05 TWD. It is the blended result of 24 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Kwong Lung Enterprise Co Ltd stock overvalued or undervalued in 2026?
As of Nov 8, 2026, 8916 trades below its calculated fair value: price 40.05 TWD, fair value 47.58 TWD, a gap of about +19% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 8916?
No. The price is what the market pays today (40.05 TWD); the fair value is what the company's own numbers justify (47.58 TWD). For Kwong Lung Enterprise Co Ltd the two are 7.53 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Kwong Lung Enterprise Co Ltd worth?
The market values Kwong Lung Enterprise Co Ltd at about 6.0B TWD (market capitalisation, as of Nov 8, 2026). Per share that is 40.05 TWD; our models calculate a fair value of 47.58 TWD per share.
What do the bullish and bearish scenarios say about 8916?
Our models span a range for Kwong Lung Enterprise Co Ltd: cautious scenario 32.32 TWD, base 47.58 TWD, optimistic 62.95 TWD per share (as of Nov 8, 2026, price 40.05 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 8916?
Kwong Lung Enterprise Co Ltd trades at a price-to-earnings ratio of 14.0 (as of Nov 8, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 47.58 TWD is built from several models across several years. Median P/E at fiscal year-end, 9 fiscal years (2016 to 2025), reported earnings: 12.1. Other multiples: P/B 1.1, P/S 0.7, EV/EBITDA 12.7.
How solid is the balance sheet of Kwong Lung Enterprise Co Ltd (8916)?
Balance-sheet figures for Kwong Lung Enterprise Co Ltd (as of Nov 8, 2026): return on equity 8.6%, debt of 0.14 per unit of equity. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is 8916 from its 52-week high?
Kwong Lung Enterprise Co Ltd trades at 40.05 TWD, about 15% below its 52-week high of 47.05 TWD and 3% above the low of 38.82 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 47.58 TWD is for.
Which stocks are comparable to Kwong Lung Enterprise Co Ltd?
From the same area (Consumer Cyclical) we also value Tongkun Group, Shenzhou International Group, Inner Mongolia ERDOS Resources Co, Far Eastern New Century Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kwong Lung Enterprise Co Ltd stock attractive at the current price?
The data as of Nov 8, 2026: price 40.05 TWD, calculated fair value 47.58 TWD (+19%), Quality Score 65/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 8916 calculated?
We run Kwong Lung Enterprise Co Ltd through 24 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 47.58 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Kwong Lung Enterprise Co Ltd currently trades 16% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kwong Lung Enterprise Co Ltd (8916)?
The closing price on Nov 9, 2026 was 40.05 TWD. Our model-based fair value is 47.58 TWD, about +19% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kwong Lung Enterprise Co Ltd right now?
A fairly wide model range (32.32 TWD to 62.95 TWD) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Key figures of Kwong Lung Enterprise Co Ltd
How large is the market capitalisation of Kwong Lung Enterprise Co Ltd (8916)?
The market capitalisation of Kwong Lung Enterprise Co Ltd is 6.0B TWD (≈ $183M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Kwong Lung Enterprise Co Ltd (8916)?
The price-to-sales ratio of Kwong Lung Enterprise Co Ltd is 0.74 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Kwong Lung Enterprise Co Ltd (8916)?
Earnings per share at Kwong Lung Enterprise Co Ltd are 2.86 TWD (price ÷ EPS = P/E 14.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Kwong Lung Enterprise Co Ltd (8916)?
The dividend yield of Kwong Lung Enterprise Co Ltd is 6.2% (payout 87.4%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Kwong Lung Enterprise Co Ltd (8916)?
The net margin of Kwong Lung Enterprise Co Ltd is 5.3% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kwong Lung Enterprise Co Ltd (8916)?
The return on equity (ROE) of Kwong Lung Enterprise Co Ltd is 8.6% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kwong Lung Enterprise Co Ltd (8916)?
On an EBIT basis the return on assets of Kwong Lung Enterprise Co Ltd is 6.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kwong Lung Enterprise Co Ltd (8916)?
The operating margin of Kwong Lung Enterprise Co Ltd is 5.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kwong Lung Enterprise Co Ltd (8916)?
Revenue at Kwong Lung Enterprise Co Ltd is growing −6.4% versus a year earlier (3y avg −6.1%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kwong Lung Enterprise Co Ltd (8916)?
Earnings per share at Kwong Lung Enterprise Co Ltd are growing +81.7% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Kwong Lung Enterprise Co Ltd (8916) carry?
The net debt of Kwong Lung Enterprise Co Ltd is 2.1B TWD (fiscal year 2025, ≈ 2.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Kwong Lung Enterprise Co Ltd in the live analysis
One click puts Kwong Lung Enterprise Co Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Broad data
Nov 8, 2026